Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4134226

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of PI3Kdelta in anti-CD3/CD28 stimulated human PBMC derived CD4-positive T cells assessed as reduction in T cell differentiation to Th17 cells by measuring IL-17A level after 72 hrs by ELISA
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Publication

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.
Hoegenauer K, Soldermann N, Zécri F, Strang RS, Graveleau N, Wolf RM, Cooke NG, Smith AB, Hollingworth GJ, Blanz J, Gutmann S, Rummel G, Littlewood-Evans A, Burkhart C.
ACS Med Chem Lett (2017) 8 : 975 -980
PubMed 28947947 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 1 7.14 7.14

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3643413 LENIOLISIB 4.0 1 7.14

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3643413 LENIOLISIB IC50 = 73.0 nM 7.14